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Escherichia  (E.)  coli producing  extended-spectrum  beta-lactamases  (ESBLs)  are an  increasing  problem  for
public  health.  The  success  of  ESBLs  may  be  due  to spread  of  ESBL-producing  bacterial  clones,  transfer
of  ESBL  gene-carrying  plasmids  or  exchange  of ESBL  encoding  genes  on  mobile  elements.  This  makes  it
difﬁcult  to identify  transmission  routes  and  sources  for ESBL-producing  bacteria.  The  objectives  of  this
study  were  to compare  the distribution  of genotypic  and  phenotypic  properties  of  E.  coli  isolates  from
different  animal  and human  sources  collected  in studies  in the  scope  of the  national  research  project
RESET.  ESBL-producing  E.  coli from  two longitudinal  and four cross-sectional  studies  in  broiler,  swine  and
cattle  farms,  a cross-sectional  and a case–control  study  in  humans  and  diagnostic  isolates  from  humans
and  animals  were  used.  In the  RESET  consortium,  all  laboratories  followed  harmonized  methodologies
for  antimicrobial  susceptibility  testing,  conﬁrmation  of  the ESBL  phenotype,  speciﬁc  PCR  assays  for  the
detection  of  blaTEM, blaCTX, and  blaSHV genes  and  sequence  analysis  of  the  complete  ESBL  gene  as  well  as
a  multiplex  PCR  for the  detection  of the four major  phylogenetic  groups  of  E. coli.  Most ESBL  genes  were
found  in both,  human  and non-human  populations  but  quantitative  differences  for distinct  ESBL-types
were  detectable.  The  enzymes  CTX-M-1  (63.3%  of  all animal  isolates,  29.3%  of all  human  isolates),  CTX-
M-15  (17.7%  vs.  48.0%)  and  CTX-M-14  (5.3%  vs. 8.7%)  were  the most  common  ones.  More  than  70%  of  the
animal  isolates  and more  than  50%  of  the human  isolates  contained  the  broadly  distributed  ESBL  genes
blaCTX-M-1, blaCTX-M-15, or the  combinations  blaSHV-12 +  blaTEM or blaCTX-M-1 + blaTEM. While  the  majority  of
animal  isolates  carried  blaCTX-M-1 (37.5%)  or  the combination  blaCTX-M-1 + blaTEM (25.8%), this  was  the case
for only  16.7%  and  12.6%,  respectively,  of the  human  isolates.  In  contrast,  28.2%  of  the  human  isolates
red  to  10.8%  of  the animal  isolates.carried  bla compaCTX-M-15
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438-4221/© 2014 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
icenses/by-nc-nd/3.0/).
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When  grouping  data  by  ESBL  types  and  phylogroups  blaCTX-M-1 genes,  mostly  combined  with  phylogroup  A
or B1,  were  detected  frequently  in all  settings.  In contrast,  blaCTX-M-15 genes  common  in human  and  animal
populations  were  mainly  combined  with  phylogroup  A, but  not  with  the more  virulent  phylogroup  B2
with the exception  of  companion  animals,  where  a few  isolates  were  detectable.
When E. coli subtype  deﬁnition  included  ESBL  types,  phylogenetic  grouping  and  antimicrobial  suscepti-
bility  data,  the  proportion  of  isolates  allocated  to  common  clusters  was  markedly  reduced.  Nevertheless,
relevant  proportions  of  same  subtypes  were  detected  in isolates  from  the  human  and  livestock  and  com-
panion  animal  populations  included  in this  study,  suggesting  exchange  of  bacteria  or bacterial  genes
between  these  populations  or a  common  reservoir.  In  addition,  these  results  clearly  showed  that  there  is
some  similarity  between  ESBL  genes,  and  bacterial  properties  in isolates  from  the  different  populations.
Finally,  our  current  approach  provides  good  insight  into  common  and  population-speciﬁc  clusters,  which
can  be  used  as  a basis  for the selection  of  ESBL-producing  isolates  from  interesting  clusters  for  further
detailed  characterizations,  e.g.  by whole  genome  sequencing.
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Most bacterial pathogens associated with human enteric illness
riginate from animals and can be transmitted directly from ani-
als to humans or indirectly, e.g. through food of animal origin,
ontaminated water or a common reservoir (Schlundt et al., 2004;
ewell et al., 2010). This multitude of potential exposure routes and
ources complicates epidemiological investigations. There is plenty
f interaction between living beings, including humans, animals
nd – at the microbial level – their commensal bacteria as well as
heir facultative and obligate bacterial pathogens, sharing the same
nvironment. Moreover, the horizontal gene transfer facilitates the
pread of resistance genes in and between various bacterial species.
o better understand these links and to identify options to reduce
he spread of resistance and infections in humans, an integrative
pproach like ‘One Health’ is needed (Parmley et al., 2013; Calistri
t al., 2013). It is assumed that by application of a global integra-
ive concept, which utilizes a cross-sectoral data interpretation of
oonotic disease information, the prevention, prediction and con-
rol of zoonotic diseases can be improved (Wendt et al., 2014;
armena and Cardona, 2014).
Third and fourth generation cephalosporins are critically impor-
ant antimicrobials as deﬁned by the World Health Organisation
www.who.int). In Enterobacteriaceae, resistance to these antimi-
robial agents is caused by the production of extended-spectrum
eta-lactamases (ESBLs). Especially, ESBL-producing Escherichia
E.) coli represent an increasing problem for public health (ECDC,
011a,b). Among ESBLs, the CTX-M-type enzymes are most com-
on  and their number has increased rapidly during the last 10
ears (Cantón et al., 2012; Carattoli, 2013). Apart from the occur-
ence in hospitalized patients, the spread of ESBL-producing E. coli
ithin the human general population seems to be quite important
Eller et al., 2012; Leistner et al., 2013; Valenza et al., 2013; Rogers
t al., 2011). Furthermore, travel to endemic countries with high
revalence rates for ESBL-producing Enterobacteriaceae (Peirano
t al., 2011; Von Wintersdorff et al., 2014) and contact to pets
re described as risk factors for colonization (Meyer et al., 2012),
hile another study identiﬁed human-to-human contact as a key
actor in the dissemination of ESBL-producing bacteria among
umans (Wu et al., 2013). Livestock and animal-derived foods
re considered relevant sources for the colonization of humans
ith ESBL-E.  coli (Sharp et al., 2014a; Hille et al., 2014). The
ame ESBL genes, ESBL gene carrying plasmids or even the same
SBL-producing E. coli isolates could be detected in animals and
he farmers taking care for them (Dierikx et al., 2013a; Moodley
nd Guardabassi, 2009; Hammerum et al., 2014). Furthermore, a
igher incidence of ESBL-producing E. coli was described for horse
wners and persons having contact to horses or several pet species
Huijbers et al., 2013). In a case–control study, consumption of pork
as shown as a risk factor for colonization with ESBL-producing by  Elsevier  GmbH.  This  is  an open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
E. coli (Leistner et al., 2013). Recent studies have shown frequent
colonization of poultry (Kola et al., 2012; Leverstein-van Hall
et al., 2011; Overdevest et al., 2011; Kluytmans et al., 2012), cattle
(Schmid et al., 2013; Reist et al., 2013), pigs (Friese et al., 2013; Von
Salviati et al., 2014) and other animal species, e.g. dogs, horses,
rats, wild birds (EFSA, 2011; Ewers et al., 2012, Guenther et al.,
2011) with ESBL-producing bacteria. Based on comparison of the
ESBL genes found there, it is assumed that foodborne exposure
has an impact on the probability of human colonization and/or
infection caused by ESBL-producing bacteria (Leverstein-van Hall
et al., 2011; Overdevest et al., 2011; Depoorter et al., 2012).
Source attribution methods allocate cases of foodborne disease
to the vehicle food or other sources responsible for illness or
colonization. Identifying and quantifying the contribution of the
different sources to zoonotic human infection or colonization is
an important ﬁrst step in efforts to reduce the exposure of the
consumer to zoonotic pathogens. The principle of the microbial
subtyping approach is to compare the subtypes of isolates from
different animal and food sources with the subtypes of bacteria
isolated from humans (Hald et al., 2007; Sharp et al., 2014b).
Recently, a ﬁrst approach was  described to quantify the proportion
of human isolates which match isolates found in animal popu-
lations (Valentin et al., 2013). More traditional, epidemiological
and statistical methods have been used to compare different
data sets and to estimate the proportion of similarity between
the different data sets. The detection of bacteria with the same
properties may  provide hints towards a possible transmission
between different populations or production stages (e.g. along the
food processing chain) or a common exposure source. Recently,
a proportional similarity index was calculated when comparing
typing patterns from methicillin-resistant Staphylococcus aureus
(MRSA) isolates from two different populations (Vossenkuhl et al.,
2014). In another approach, a statistical method was described to
investigate linkages in phenotypic resistance proﬁles in a popu-
lation sample of Salmonella Typhimurium isolates from sporadic
salmonellosis cases which can be used to identify linked resistance
in isolates from different populations (Ruddat et al., 2012).
The objectives of the present study were to analyze the geno-
typic and phenotypic properties of ESBL-producing E. coli isolates
from different animal and human sources and to identify common
and distinct isolate subgroups based on typing results. Different
questions were addressed: (i) which subgroups may be identiﬁed;
(ii) which subgroups are common to humans and to speciﬁc ani-
mal  populations and how are these subgroups distributed among
the species and (iii) are there subgroups of ESBL-producing E. coli
isolates which are unique for a population? The outcome of this
study may  support the decisions which isolates should be selected
for an in-depth characterization, e.g. by whole genome sequenc-
ing, since it may  show the relationship of common subtypes and
identify the properties of unique subtypes in a strain collection.
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rigin of the isolates
The national interdisciplinary research project RESET
www.reset-verbund.de) is a consortium of ten partners from
eterinary medicine, human medicine and public health insti-
utes. In the scope of the RESET project, ESBL-producing E. coli
rom humans and animals were investigated in several stud-
es since 2011. In livestock populations, two longitudinal and
our cross-sectional studies were performed to collect potential
SBL-producing E. coli using MacConkey agar containing 1 mg/L
efotaxime as selective medium. In the longitudinal studies, faecal
nd environmental samples from seven broiler and seven swine
arms were taken at the beginning, in the middle and at the end of
heir fattening period (Laube et al., 2013; Von Salviati et al., 2014;
riese et al., 2013). In one cross-sectional study, faecal samples,
oot swabs, and dust samples from 30 mixed dairy and beef cattle
arms (3 age groups) and 15 beef cattle farms (2 age groups) were
ampled in the southern part of Bavaria, Germany (Schmid et al.,
013). In other cross-sectional studies following the same protocol,
4 broiler, 48 pig and 42 cattle farms (2 age groups if available)
epresenting different regions of Germany were investigated
Hering et al., 2014a,b,c). In each of the studies, different samples
ere tested, which made several isolates available for further
yping. For each farm included in the studies duplicates showing
he same pattern were identiﬁed. Only one isolate of each pattern
er farm was used for this analysis.
To include also clinical isolates in the analysis, E. coli isolates
rom routine monitoring programs on antimicrobial resistance in
nimal pathogens (GERM-Vet, Bft-GermVet), but also from diag-
ostic submissions were used. These isolates covered livestock
opulations (poultry, swine, cattle) and companion animals (dogs
nd horses) from all regions of Germany. The isolates were already
vailable in strain collections of the Federal Ofﬁce of Consumer
rotection and Food Safety, Berlin, the Institute of Farm Animal
enetics, Friedrich-Loefﬂer-Institut, Neustadt-Mariensee, and the
nstitute of Hygiene and Infectious Diseases of Animals, Justus
iebig University Gießen (GERMAP, 2008; Schink et al., 2011, 2013;
chmiedel et al., 2014).
Within further studies ESBL-producing E. coli isolates were col-
ected from healthy humans, outpatients and hospitalized patients.
he presence of ESBL-producing E. coli was determined among
344 study participants from the German community (Valenza
t al., 2014). Moreover, isolates from hospitalized patients were
ollected within a matched case–control study at the Charité Uni-
ersity Hospital Berlin. Cases were deﬁned as patients colonized
ith community-acquired ESBL-producing E. coli identiﬁed <72 h
fter hospital admission (Leistner et al., 2013). Furthermore, ESBL-
roducing E. coli isolates from ambulant and nosocomial infections
ere collected by several laboratories and were submitted to the
obert Koch Institute and the Institute for Medical Microbiology of
he Justus Liebig University Gießen (Pfeifer and Eller, 2012; Pfeifer
t al., 2013; Schmiedel et al., 2014).
Overall, a rather comprehensive set of isolates was available
rom several epidemiological as well as molecular-epidemiological
tudies, which represents the most common ESBL-producing E. coli
trains in each of the animal populations as well as the human
opulation investigated.
ntimicrobial susceptibility testing and molecular typingIn the consortium RESET, all different laboratories followed a
armonized methodology. The potentially ESBL-producing E. coli
solates were tested for their antimicrobial susceptibility to
ephalosporins (CLSI, 2012, EUCAST (www.eucast.org)) and allical Microbiology 304 (2014) 805–816 807
isolates showing resistance to 3rd generation cephalosporins
(cefotaxime and/or ceftazidime) were subjected to further char-
acterization (Guerra et al., 2012; Pfeifer et al., 2013). First, the
ESBL phenotype of the potentially ESBL-producing E. coli iso-
lates was  conﬁrmed by antimicrobial susceptibility testing (CLSI,
2012; EUCAST; Michael et al., 2014). Then, the ESBL-producing
isolates were characterized by different pheno- and genotypic
methods, including (i) antimicrobial susceptibility testing by the
CLSI broth microdilution method (CLSI, 2012), the CLSI disc dif-
fusion method (CLSI, 2012) or VITEK®2 compact system with AST
N117 cards (bioMérieux) and Etest® stripes (Lioﬁlchem®) contain-
ing ertapenem, cefepime, chloramphenicol and nalidixic acid, (ii)
speciﬁc PCR assays for the detection of ESBL blaTEM, blaCTX, and
blaSHV genes and sequence analysis of the complete ESBL gene
(Rodríguez et al., 2009), and (iii) a multiplex PCR for the detection
of the four major phylogenetic groups of E. coli (Clermont et al.,
2000). Sequence analysis of blaTEM genes focused on those isolates,
in which no ESBL variants of blaCTX-M or blaSHV genes were present.
For the purpose of this study, results of the antimicro-
bial susceptibility testing of gentamicin, chloramphenicol and
sulfamethoxazole/trimethoprim were interpreted using com-
mon  breakpoints, derived from EUCAST clinical breakpoints
(www.eucast.org). For the analysis of antimicrobial resistance pat-
tern, isolates were classiﬁed as susceptible (below or equal to
breakpoint) or non-susceptible (above breakpoint for intermediate
or resistant). For the latter, the term ‘resistant’ is used through this
document. The results obtained with these typing methods were
used for the categorization of the isolates, which is explained in
the following sub-section.
Approach for the categorization of isolates and analysis
The basis of these comparisons is a series of standardization and
harmonization within the RESET consortium, as well in laboratory
techniques as in the documentation and statistical analyses of the
data generated. Based on this, all data were stored in a common
database and used for this analysis.
For the analysis of the data, the sources were categorized in dif-
ferent ways. Distinction was  made (i) between samples collected
within epidemiological studies (screening) or diagnostic investi-
gations (diagnostic) and (ii) in some approaches between livestock
and companion animals or the individual animal species (livestock:
chicken, cattle, pigs; companion animals: dogs, horses). Human
ESBL-producing E. coli isolates were collected from the general pop-
ulation, outpatients (ambulant isolates) and hospitalized patients
(nosocomial isolates). An overview is given in Table 1.
The following genotypic and phenotypic properties of the
isolates from all studies were used for the analyses: (1) pres-
ence of ESBL genes of the CTX-M- and/or SHV-families and/or
TEM-family irrespective if this was  speciﬁc for ESBL-production,
(2) E. coli phylogenetic group and (3) additional resistance to
gentamicin (R > 2 mg/l), chloramphenicol (R > 8 mg/l) and sul-
famethoxazole/trimethoprim (R > 4 mg/l). The ESBL genes give
insight into the genetic background for the phenotypically
observed production of ESBLs and the genes are transferable
between plasmids and bacterial strains. The phylogenetic grouping
was used to obtain some preliminary information on the genetic
background of these bacteria and the pathogenicity of the E. coli
strains. Additional information on resistance to gentamicin, chlor-
amphenicol and sulfamethoxazole/trimethoprim was  used, as the
related resistance genes are usually located within multi-drug
resistance regions on conjugative plasmids, which might be trans-
ferred together with the ESBL genes between bacterial isolates.
Preliminary analysis of resistance data had shown that each
of these antimicrobial agents split isolates into a susceptible and
resistant class of sufﬁcient size (data not shown). The variable
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Table 1
Overview of the isolates (n = 1329) used for pattern analysis and categorization in a study subgrouping ESBL-producing E. coli from animal and human sources in Germany.
Group Study type Number of isolates per study type Source Number of isolates per source
Livestock
Screening 297 Chicken 38
Cattle 120
Pigs 139
Diagnostic 287  Chicken 11
Cattle 203
Pigs 73
Companion animals
Diagnostic 110 Dogs 29
Horses 81
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Screening, diagnostic 635 
resistance pattern’ used in the analysis was deﬁned by combin-
ng the results for the two substances and the combination of
ubstances tested (gentamicin, chloramphenicol, sulfamethoxa-
ole/trimethoprim) to one term, e.g. RRS for an isolate with values
bove the breakpoint for gentamicin and chloramphenicol, but
elow the breakpoint for sulfamethoxazole/trimethoprim. Simi-
arly, the ESBL genes (blaCTX-M; blaSHV) and presence of any blaTEM
ene were combined to one variable ‘genes’, e.g. ‘1.12.+’ for an iso-
ate producing the ESBL-speciﬁc enzymes CTX-M-1 and SHV-12 and
 not further characterized TEM.
Four different approaches to categorize the isolates were
pplied:
(A) Presence of different ESBL types (CTX-M; SHV) and any TEM
type
(B) Combination of the presence of different ESBL types, any TEM
type and the phylogenetic group
(C) Combination of the presence of different ESBL types, any TEM
type and the resistance pattern to the aforementioned two
antimicrobials and the combination of substances
D) Combination of the presence of different ESBL types, any TEM
type, the phylogenetic group and the resistance pattern.
Besides considering each animal population separately, differ-
nt animal groups were deﬁned for the analysis. Priority was given
o the reason for sampling, i.e. only diagnostic isolates or screening
solates were grouped together, and a separation between livestock
nimals and companion animals resulting in three groups, namely
ivestock screening, livestock diagnostic and companion animals
iagnostic (Table 1). All human isolates, irrespective of the type of
tudy, were grouped together reﬂecting the focus of this analysis.
To compare strain patterns, different combinations of the animal
roups were tested for their similarity with human isolates. Details
n the combinations compared are given in Table 2.
esults
vailability of strains by source and typing data
A total of 1329 E. coli isolates showed the presence of at least one
SBL gene and were included in the analysis. They were originat-
ng from screening livestock populations (297 isolates), diagnostic
amples of livestock (287 isolates) or companion animals (110 iso-
ates). Furthermore, 635 isolates from humans originating from
ifferent regions of Germany were used (Table 1). In total, the data
et comprised 15 different variants of the ESBL blaCTX-M gene (CTX-
-1, -15, -14, -2, -3, -27, -55, -9, -24, -32, -79, -97, -8, -104, -117 in
rder of frequency), three variants of the ESBL blaSHV gene (SHV-12,
2a, -2), and at least four variants of the blaTEM gene (TEM-52, -1,
12, -20 in order of frequency). Most common were the enzymesGeneral population 213
Ambulant cases 145
Nosocomial cases 277
CTX-M-1 (n = 625, 47.0%), CTX-M-15 (n = 428, 32.2%) and CTX-M-
14 (n = 92, 6.9%). Phylogenetic grouping revealed the presence of
E. coli belonging to the groups A, B1, B2 and D in different quantities
for every study population. Overall E. coli of phylogenetic groups
A (n = 534; 40.2%), B1 (n = 301; 22.6%), B2 (n = 218; 16.4%) and D
(n = 276; 20.8%) were detected.
In the analyses of the resistance data, eight resistance patterns
were observed. Resistance to sulfamethoxazole/trimethoprim was
most frequent (1019 isolates, 76.7%), followed by resistance to
chloramphenicol (612 isolates, 46.0%) and gentamicin (453 iso-
lates, 34.1%). Among the animal isolates, the proportion of resistant
isolates was  highest among companion animals for all three antimi-
crobials, followed by diagnostic isolates from livestock. There was
no common tendency when all human and animal isolates were
compared (resistance to sulfamethoxazole/trimethoprim 85.7% for
human isolates vs. 68.4% for animal isolates; chloramphenicol
40.0% vs. 51.6%; gentamicin 32.3% vs. 35.7%), but resistance rates for
each antimicrobial in screening isolates from livestock were below
those from human isolates. Among livestock, isolates from cattle
tended to have the highest resistance rates.
Grouping data by ESBL types and blaTEM gene (approach A)
In the dataset, the enzymes CTX-M-1 (63.3% of all animal iso-
lates, 29.3% of all human isolates), CTX-M-15 (17.7% vs. 48.0%) and
CTX-M-14 (5.3% vs. 8.7%) were the most common. Classiﬁcation of
the isolates by the presence of the ESBL gene types (blaCTX-M-type,
blaSHV-type) and the blaTEM genes revealed 35 different patterns
(including combinations of the genes). More than 70% of the ani-
mal  isolates and more than 50% of the human isolates contained
the broadly distributed ESBL genes blaCTX-M-1, blaCTX-M-15, or the
combinations blaSHV-12 + blaTEM or blaCTX-M-1 + blaTEM (categories
1a–c, Tables 2 and 3). The distribution of these four types between
animal and human isolates was quite different. While the major-
ity of animal isolates carried blaCTX-M-1 (37.5%) or the combination
blaCTX-M-1 + blaTEM (25.8%), this was  the case for only 16.7% and
12.6%, respectively, of the human isolates. In contrast, 28.2% of the
human isolates carried blaCTX-M-15 compared to 10.8% of the ani-
mal  isolates. Furthermore, in the category 1c, which required the
presence of the genes only in the three screened livestock popu-
lations, some isolates from all origins belonged to the ESBL type
blaSHV-12 + blaTEM (1.0% animal isolates vs. 0.6% human isolates).
Subtypes with limited distribution among the animal popula-
tions (categories 1d–h, Table 2), but present in the human isolates
could also be identiﬁed, but each of the subtypes comprised only
a few isolates (Table 3). Similarly, unique patterns found in spe-
ciﬁc animal populations and in the human population (categories
2a–h, Table 2) were detected among isolates from pigs (screening
isolates; blaCTX-M-24; blaCTX-M-24 + blaTEM; blaCTX-M-9), cattle (diag-
nostic isolates; blaCTX-M-3 + blaTEM) and horses (diagnostic isolates;
blaCTX-M-97 + blaTEM). Only three animal isolates (one isolate from
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Table  2
Deﬁnition of the categories and subgroups of animal populations for comparison purposes in a study subgrouping ESBL-producing E. coli from animal and human sources
in  Germany.
Category *
Screening or 
diagnostic samples
Chicken Cattle Pig Chicken Cattle Pig Dog Horse Humans
1 a) + + + + + + + + +
b) + + + +a +a +a +b +b +
c) + + + +
d) + + + +
e) + + + +
f) a a a b b +
g) a a a +b +b +b c c +
h) a a a b b b +c +c +
i) a a a b b b c c +
j) +a +a +a +b +b +b +c +c
2 a) + +
b) + +
c) + +
d) + +
e) + +
f) + +
g) + +
h) + +
3 a) +
b) +
c) +
d) +
e) +
f) +
g) +
h) +
4 +
+
+
Screening samples Diagnostic samples Diagnostic samples
a For the analysis, the three livestock populations (cattle, pigs, broiler) sampled by screening methods or within diagnostic investigations as well as the companion
ected
ly with
tegor
a
w
p
i
t
T
c
(animals (dogs, horses) were either considered separately or as a group. This is reﬂ
by  /= if excluded; empty if not considered) or marking several species additional
categories, please refer to the text. Results are given referring to these different ca
 pig; two isolates from chickens) showed unique patterns which
ere not present in any of the other populations (including human
opulation) (categories 3a-3h, Table 2). In total, 25 isolates reﬂect-
ng four subtypes belonged to patterns which were present in
he three animal groups, but not in human isolates (category 1j,
able 2). Thirteen different subtypes, reﬂecting 48 human isolates,
ould not be identiﬁed in any of the animal isolates investigated
category 4, Table 2). by either giving each species a separate sign (marked by + if considered, marked
 the same letter if considered as a group. For further explanation of the different
ies (combinations of animal species and humans) to assist understanding.
Grouping data by ESBL types, blaTEM gene and phylogenetic
groups (approach B)
Overall E. coli phylogenic groups A (51.7% of all animal isolates,
27.6% of all human isolates), B1 (28.8% and 15.9%, respectively), B2
(2.7% and 31.3%, respectively) and D (16.7% and 25.2%, respectively)
were detected. Using the combination of ESBL types, any blaTEM
gene and phylogenetic groups, 89 different patterns were observed.
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Table 3
Results of comparison of E. coli isolates on the basis of subgrouping approach A (ESBL subtypes) in a study subgrouping ESBL-producing E. coli from animal and human sources
in  Germany.
Category Number of animal isolates out
of 694 isolates matching the
patterns (proportion of all
isolates)
Number of human isolates out
of 635 isolates matching the
patterns (proportion of all
isolates)
Number of subtypes
(ESBL subtypes
detecteda)
Broadly distributed subtypes in animal and human isolates (available in all animal populations considered and in the human population)
1a)  in each of the 8 animal populations
514 (74.1%) 365 (57.5%) 3
(CTX-M-1, TEM;
CTX-M-1;
CTX-M-15)
179 (25.8%) 80 (12.6%)
260 (37.5%) 106 (16.7%)
75 (10.8%) 179 (28.2%)
1b)  in each of the 3 animal populations
screened, in the diagnostic livestock
sample and in the diagnostic
companion animal sample
514 (74.1%) 365 (57.5%) 3
(CTX-M-1, TEM;
CTX-M-1;
CTX-M-15)
179 (25.8%) 80 (12.6%)
260 (37.5%) 106 (16.7%)
75 (10.8%) 179 (28.2%)
1c)  in each of the 3 livestock
populations screened (other animal
populations are not considered)
521 (75.1%) 369 (58.1%) 4
(CTX-M-1, TEM;
CTX-M-1;
CTX-M-15;
SHV-12, TEM)
179  (25.8%) 80 (12.6%)
260 (37.5%) 106 (16.7%)
75 (10.8%) 179 (28.2%)
7  (1.0%) 4 (0.6%)
Subtypes with limited distribution in animal and human isolates (available in only few animal populations considered and in the human population)
1d)  in each livestock population
screened but not in diagnostic
isolates (n = 381 isolates)
0 0 0
1e)  in each livestock population
screened and in diagnostic livestock
isolates but not diagnostic isolates
from companion animals
0 0 0
1f)  only in any of the livestock
populations screened, but not in any of
the diagnostic isolates
6 (0.9%) 5 (0.8%) 3
(CTX-M-24, TEM;
CTX-M-24;
CTX-M-9)
4  (0.6%) 1 (0.2%)
1  (0.1%) 1 (0.2%)
1  (0.1%) 3 (0.5%)
1g)  only in diagnostic isolates from
livestock but not in livestock isolates
from screening or from companion
animals
1 (0.1%) 7 (1.1%) 1 (CTX-M-3, TEM)
1h)  only in diagnostic isolates from
companion animals, but not in any of
the other animal populations
3 (0.4%) 1 (0.2%) 1 (CTX-M-97, TEM)
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ga TEM – as not all blaTEM genes were sequenced, details for the TEM-type (even if
n total, 55 patterns were observed in animal populations and 69
atterns in human populations.
In line with the more diverse patterns observed, the number of
solates belonging to common patterns was lower (Fig. 1). More
han 40% of the animal isolates and more than 20% of the human
solates contained broadly distributed subtypes (categories 1b-1c,
ables 2 and 4), namely blaCTX-M-1 in combination with one of the
hylogenetic groups or blaCTX-M-15 in combination with phylogroup
 (Table 4). The combinations of blaCTX-M-1 and phylogroups A or
1 were more frequently present in animal isolates compared to
uman isolates (Table 4).
Subtypes with limited distribution among the animal popula-
ions, but present in human isolates (categories 1d-1h) could also
e identiﬁed, but the proportion of all animal isolates was below
% (Table 4). Ten isolates from diagnostic samples from compan-
on animals belonged to subgroups which were not present in any
ivestock populations, but represented 12.6% of all human isolates
category 1h, Table 4). Among these ﬁndings were blaCTX-M-15 in
ombination with phylogroup B2.
Unique patterns between one animal population and the human
opulation (categories 2a-2h, Table 2) were detected in isolates
rom cattle, chicken, horses and dogs but not in isolates from pigs.
ixteen unique patterns, which were not present in any of the other
eﬁned populations, were seen among 24 animal isolates (cate-
ories 3a-3h, Table 2). Twenty patterns (44 isolates) were presentble) are not given.
in the three animal groups, but not in the human isolates (category
1j, Table 2). Finally, 34 different patterns, reﬂecting 118 human iso-
lates (18.6%), could not be identiﬁed in any of the animal isolates
investigated (category 4, Table 2).
Grouping data by ESBL types, blaTEM gene and resistance patterns
(approach C)
A total of 121 different combinations of ESBL genes, any blaTEM
gene and resistance proﬁles (combination of the three antimi-
crobials used for classiﬁcation) were present in the data set.
Only one pattern (blaCTX-M-15 + RRR) could be identiﬁed, which
was common in each of the eight animal populations (4.2% of
all animal isolates) and in the human population (5.2% of all
human isolates) (category 1a, Table 2, Fig. 2). In total 34.7% of
the isolates from the three screening livestock populations and
20.6% of the human isolates belonged to the same subgroups
(category 1c, Table 2, Fig. 2). Most frequently, isolates with the
patterns blaCTX-M-1 + SSS (susceptible to all three tested antimi-
crobials; 91 animal isolates, 13.1%; 20 human isolates, 3.1%) and
blaCTX-M-1 + SSR (resistance to sulfamethoxazole/trimethoprim; 67
animal isolates, 9.7%; 51 human isolates, 8.0%) were detected. There
was one type (blaSHV-12 + blaTEM + SRR) unique for the screened
livestock populations and humans (category 1d) and two pat-
terns [blaCTX-M-1 + blaTEM + SSR, 50 (7.2%) animal isolates, 25 (3.9%)
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Fig. 1. Proportion of all isolates belonging to a subgroup on the basis of the subgrouping approaches. White bars show the approach A (ESBL-type only); gray bars show the
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he  subcategories in Table 2.
uman isolates; blaCTX-M-1 + SSS, 91 (13.1%) animal isolates, 20
3.1%) human isolates] common in livestock and human isolates
category 1e).
Subtypes with limited distribution among one of the animal sub-
roups, but present in the human isolates (categories 1f-1h, Table 2)
epresented 19 distinct patterns (129 isolates) with different com-
inations of resistance.
Unique patterns (n = 15) comprising 74 isolates (21 from ani-
als and 53 from humans) between one animal population and
he human population were detected in isolates from pigs and
attle, but not in chicken (categories 2a-2h, Table 2). The pat-
erns included 7 isolates, unique for horses and humans, with
laCTX-M-2 + blaTEM + SRR (category 2d, Table 2) but no isolates,
nique for dogs and humans (category 2e, Table 2).
Thirty-four animal isolates (4.9%) showed unique patterns
n = 20), which were not present in any of the other popula-
ions (categories 3a-3h, Table 2). Twenty-eight patterns comprising
9 isolates (12.4%) were only present in livestock (screening,
iagnostic) and companion animals, but not in humans (cate-
ory 1j, Table 2). Finally, 44 different patterns among 80 human
solates (12.6%) could not be identiﬁed in any of the animal iso-
ates investigated (category 4, Table 2). All details, together with
he information on the phylogenetic groups are given in Supple-
entary Table 1.
Supplementary material related to this article can be
ound, in the online version, at http://dx.doi.org/10.1016/
.ijmm.2014.07.015.
rouping data by ESBL types, any blaTEM gene, phylogenetic
roups and resistance patterns (approach D)
Altogether in the data set, 254 different combinations of
SBL types, any blaTEM gene, phylogenetic groups and resistance
atterns, were present. The detailed results are shown in Supple-
entary Table 1. Overall, the number of unique types increased and
he proportion of isolates with common characteristics decreased. coli from animal and human sources in Germany. The designations 1a-1j represent
in several populations (Fig. 2). In total, 28.8% of the animal isolates
and 13.2% of the human isolates belonged to one of the common
subgroups present in the three screening livestock and the human
populations (category 1c, Table 2). In this category, eight different
patterns could be identiﬁed, containing blaCTX-M-1 in combination
with phylogroup A, B1 or D and the resistance patterns SSR or SSS,
or blaCTX-M-15 in combination with phylogroup A and the resis-
tance pattern RRR. None of these types was  unique for the screened
livestock population and humans (category 1d).
In total, 91 animal isolates (13.1%) showed unique patterns
(overall 61 patterns) which were not present in any of the other
populations deﬁned (categories 3a-3h, Table 2). Furthermore, 159
animal isolates (22.9%) exhibited 79 patterns, which were present
in each of the three animal groups, but not in human isolates (cat-
egory 1j, Table 2). Finally, 265 (41.7%) human isolates, reﬂecting
99 different patterns, could not be identiﬁed in any of the animal
isolates investigated (category 4, Table 2).
Discussion
In the course of the ‘One Health’ approach, several studies are
ongoing to show the potential of collaborative work from human
and veterinary medicine. This study shows an example in this
context from antimicrobial resistance research, namely on ESBL-
producing E. coli in Germany. For this, recent data was generated
with harmonized laboratory techniques from several populations
of humans and animals to analyze ESBL-producing E. coli from
different populations for similar and different properties. This
approach may  be recognized as a basic data description for a future
study of transmission of resistance between populations and
therefore was  considered as a basis for a ‘One Health’ discussion
in this context.Overall, typing data of 1329 isolates from different animal and
human sources were used to identify common and distinct patterns
among the ESBL-producing E. coli isolates. All isolates included in
the study were processed and documented following standardized
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Table 4
Results of comparison of E. coli isolates on the basis of subgrouping approach B (ESBL subtypes and phylogenetic groups) in a study subgrouping ESBL-producing E. coli from
animal and human sources in Germany.
Category Number of animal isolates out
of 694 isolates matching the
patterns (proportion of all
isolates)
Number of human isolates out
of 635 isolates matching the
patterns (proportion of all
isolates)
Number of subtypes (ESBL
subtypes and phylogroups
detecteda)
Broadly distributed subtypes in animal and human isolates (available in all animal populations considered and in the human population)
1a)  in each of the 8 animal populations 304 (43.8%) 137 (21.6%) 4
(CTX-M-1, A;
CTX-M-1, B1;
CTX-M-1, D;
CTX-M-15, A)
117 (16.9%) 37 (5.8%)
94 (13.5%) 30 (4.7%)
38 (5.5%) 22 (3.5%)
55 (7.9%) 48 (7.6%)
1b)  in each of the 3 animal populations
screened, in the diagnostic livestock
sample and in the diagnostic
companion animal sample
396 (57.1%) 160 (25.2%) 5
(CTX-M-1, A;
CTX-M-1, B1;
CTX-M-1, D;
CTX-M-15, A
CTX-M-1, TEM, A)
117  (16.9%) 23 (3.6%)
94 (13.5%) 37 (5.8%)
38 (5.5%) 30 (4.7%)
55 (7.9%) 22 (3.5%)
92 (13.3%) 48 (7.6%)
1c)  in each of the 3 livestock
populations screened (other animal
populations are not considered)
407 (58.6%) 177 (27.9%) 6
(CTX-M-1, A;
CTX-M-1, B1;
CTX-M-1, D;
CTX-M-15, A
CTX-M-1, TEM, A; CTX-M-1, B2)
117  (16.9%) 23 (3.6%)
94 (13.5%) 37 (5.8%)
38 (5.5%) 30 (4.7%)
55 (7.9%) 17 (2.7%)
92 (13.3%) 22 (3.5%)
11 (1.6%) 48 (7.6%)
Subtypes with limited distribution in animal and human isolates (available in only few animal populations considered and in the human population)
1d)  in each livestock population
screened but not in diagnostic
isolates
0 0 0
1e)  in each livestock population
screened and in diagnostic livestock
isolates but not diagnostic isolates
from companion animals
11 (1.6%) 17 (2.7%) 1 (CTX-M-1, B2)
1f)  only in any of the livestock
populations screened, but not in any of
the diagnostic isolates
6 (0.9%) 8 (1.3%) 3
(CTX-M-14, B1;
SHV-12, TEM, D;
TEM-52, D)
2  (0.3%) 2 (0.3%)
3  (0.4%) 2 (0.3%)
1  (0.1%) 4 (0.6%)
1g)  only in diagnostic isolates from
livestock but not in livestock isolates
from screening or from companion
animals
3 (0.4%) 25 (3.9%) 3
(CTX-M-14, TEM, B1;
CTX-M-14, D;
CTX-M-3, TEM, D)
1  (0.1%) 1 (0.2%)
1  (0.1%) 18 (2.8%)
1  (0.1%) 6 (0.9%)
1h)  only in diagnostic isolates from
companion animals, but not in any of
the other animal populations
10 (1.4%) 80 (12.6%) 5
(CTX-M-15, B2;
CTX-M-2, TEM, A;
CTX-M-2, TEM, D;
1  (0.1%) 76 (12.0%)
5  (0.7%) 1 (0.2%)
1  (0.1%) 1 (0.2%)
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1  (0.1%) 
TEM – as not all blaTEM genes were sequenced, details for the TEM-type (even if av
rotocols, which distinguish these data from classical strain col-
ections or even registers, among which the laboratory sampling
rocedures varied substantially and the documentation standards
ere narrow. To our knowledge, this is the ﬁrst national strain and
ata collection of that magnitude handled in this way. Recently,
29 isolates from humans, animals and animal food products in
ermany, The Netherlands and the UK were compared using a
icroarray approach (Wu  et al., 2013). To our best knowledge, sim-
lar approaches, in which phenotypic and genotypic typing data
rom such a broad strain collection have been compared, have not
et been described.
The level of homogeneity and heterogeneity was  related to
he number of typing results used for classiﬁcation. With all four
pproaches, used for the classiﬁcation of the isolates, common
ubgroups of isolates could be identiﬁed between animal and
uman populations. This points towards common resistance genes
nd/or plasmids in several or even all populations, which might
e explained by an exchange between them or common exposure
ources.CTX-M-2, B1;
CTX-M-97, TEM, A)
1 (0.2%)
1 (0.2%)
e) are not given.
In addition, unique subtypes could be determined. For example,
some ESBL genes, partly in combination with blaTEM genes were
present only in one population. If additional information (phylo-
genetic group, resistance pattern) was  included, the number of
distinct types increased. This reﬂects the huge diversity of com-
binations of the information considered, and may be interpreted
as a signal for horizontal spread of genes or plasmids. It may  be in
part related to the still limited number of isolates per population
covered in the study.
Dominating ESBL genes
In this study, more than 70% of the animal isolates and
more than 50% of the human isolates contained broadly dis-
tributed ESBL genes. This is in accordance with previous reports
in which blaCTX-M-1, blaCTX-M-15 and blaSHV-12 were most frequently
detected. Wu  and coworkers reported that blaCTX-M-group-1 genes
were widespread in all host species and in the three participating
countries. Genes of the blaCTX-M-group-1 predominated among the
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Fig. 2. Proportion of animal (a) or human (b) isolates belonging to a subgroup on the basis of the subgrouping approaches in a study subgrouping ESBL-producing E. coli from
a -type
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Enimal  and human sources in Germany. The white bars show the approach C (ESBL
hylogenetic group and antimicrobial resistance). The designations 1a-1j represent
laCTX-M genes and were detected in 66% of the isolates investi-
ated (Wu et al., 2013). In the Netherlands, among 314 randomly
elected and sequenced clinical Enterobacteriaceae of human ori-
in, blaCTX-M-15 was most prevalent (39%), followed by blaCTX-M-1
15%), blaCTX-M-14 (5%), blaSHV-12 (8%) and blaTEM-52 (4%) (Voets et al.,
012). The blaCTX-M-1 was the dominating ESBL gene detected in
erman pig and cattle farms (Guerra et al., 2012). In contrast to
revious ﬁndings, the presence of blaCTX-M-1 in human popula-
ions increased to 22% of the isolates typed (Leistner et al., 2014).
imilarly, in livestock animals, an increase of the prevalence of
SBL-producing E. coli and E. coli carrying blaCTX-M-1 genes was and antimicrobial resistance) and the gray bars show the approach D (ESBL-type,
bcategories in Table 2.
observed during the last years (Agersø et al., 2012; Dierikx et al.,
2010). These common ﬁndings and trends point towards exposure
pathways linking animal populations and humans, which should be
investigated further in more detail. In a recent study, it was shown
that blaCTX-M-15-producing isolates from non-human sources are
still rarely found in Germany (Fischer et al., 2014). The pandemic
occurrence of blaCTX-M-15-producing isolates in humans, observed
in several studies, was explained by the dissemination with the
O25:H4-ST131 E. coli clone (Rogers et al., 2011; Lau et al., 2008;
Livermore and Hawkey, 2005; Hawkey and Jones, 2009). As a pos-
sible explanation for the wide dissemination of the ST131 clone, it
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s assumed that this may  be related to an enhanced ﬁtness for colo-
ization and transmission (Johnson et al., 2012; Vimont et al., 2012).
n this study, there was no clear difference in the matching probabil-
ty between animal isolates, collected in speciﬁc studies (screening
ealthy populations using selective media) as well as those col-
ected from diagnostic samples on one hand and the human isolates
n the other hand. Unique types were identiﬁed for each of the ani-
al  populations as well as for the human population, but unique
ypes covered only a limited number of isolates (2.6% of the ani-
al  isolates, 7.3% of the human isolates). Thus, currently no major
ubtype can be identiﬁed which is speciﬁc for any of the animal
opulations.
hylogenetic groups
Out of the four major E. coli phylogenetic groups (A, B1, B2, D),
he phylogenetic groups A and B1 dominated in isolates of animal
rigin (46.9% of animal isolates, 16.5% of human isolates) whereas
n human isolates, phylogenetic groups B2 and D were detected
ore frequently. Previous studies showed that most E. coli strains
esponsible for urinary tract infections and other extraintestinal
nfections in humans belong to group B2 or, to a lesser extent, to
roup D and that strains of phylogenetic group B2 and D often carry
irulence determinants that are lacking in group A and B1 strains
Goullet and Picard, 1986; Johnson and Stell, 2000; Picard et al.,
999).
Nevertheless, isolates of the same phylogenetic group and com-
on  ESBL genes were found in the different populations. Within
his study, more than 40% of the animal isolates and more than 20%
f the human isolates contained broadly distributed ESBL genes,
amely blaCTX-M-1 in combination with any of the four phyloge-
etic groups or blaCTX-M-15 in combination with phylogenetic group
. Interestingly, ten isolates from diagnostic samples of companion
nimals belonged to subgroups which were not present in any live-
tock populations, but represented 12.1% of all human isolates. This
ay  reﬂect some intensive interaction between humans and com-
anion animals or a common reservoir for both populations which
eeds further investigations.
When phylogenetic groups were considered for grouping, the
roportion of unique subtypes increased from 2.6% to 5.7% for ani-
al  isolates and from 7.3% to 16.8% for human isolates, indicating
ifferent parent strains carrying ESBL genes in humans and animals.
his might hint towards horizontal transfer of plasmids between
hese groups. Several previous studies comparing isolates from dif-
erent origins reported similar results (Leverstein-van Hall et al.,
011; Overdevest et al., 2011).
ntimicrobial resistance patterns
Although only three antimicrobial agents were included for the
ubtyping approach involving antimicrobial resistance patterns,
here were several different combinations of resistance patterns.
ost of the isolates showed resistance to one or several of these
ntimicrobial agents and common patterns between isolates of the
ifferent populations could be observed. This may  be interpreted as
ome hint towards an exchange of plasmids which carried several
esistance genes. The proportion of isolates in common clusters was
arkedly reduced. Interestingly, 13.1% of the animal isolates and
.1% of the human isolates belonged to the subtype blaCTX-M-1 with
esistance pattern SSS (fully susceptible). Quite worrying, the pat-
ern blaCTX-M-15 RRR was present in all populations, which points
owards the widespread presence of a multiresistant subtype of
. coli,  carrying an ESBL gene originally more commonly found in
umans. The resistance pattern RRR was linked with phylogroup B2
n human isolates, and with phylogroup D in isolates from humans,
ompanion animals and one isolate from cattle. This may  reﬂectical Microbiology 304 (2014) 805–816
a direct or indirect transfer between humans and animals or the
exchange of strains or plasmids while sharing the same environ-
ment. Several studies had shown that persons having direct contact
to animals carry similar strains or strains with similar plasmids
(Dierikx et al., 2013a; Moodley and Guardabassi, 2009; Huijbers
et al., 2013; Meyer et al., 2012). The proportion of unique subtypes
increased in this approach to 4.9% for animal isolates and 12.6%
for human isolates when using several typing results for classiﬁca-
tion. Thus, the results show that the information on antimicrobial
resistance patterns gives useful additional information to identify
common and unique strains.
Conclusions
The study showed the beneﬁt from following an integrated
approach for analyzing isolates representing different populations
for their similarity and possible relevance for exposure of other
populations. A detailed understanding of these interactions is a pre-
requisite for the identiﬁcation and implementation of appropriate
control measures. One outcome from this research is the agree-
ment on and application of common methods, applied on actively
collected isolates with detailed knowledge and storage of data in
one dataset.
Following different grouping approaches, a relevant propor-
tion of indistinguishable subtypes was detected in the human and
animal populations, reﬂecting that some interaction or exposure
cannot be ruled out and need further investigation. For exam-
ple, more than 70% of the animal isolates and more than 50% of
the human isolates contained the broadly distributed ESBL genes
blaCTX-M-1, blaCTX-M-15, or the combinations blaSHV-12 + blaTEM or
blaCTX-M-1 + blaTEM. Additionally, these results clearly showed that
there are some similarities between genes and bacterial prop-
erties in isolates from the different populations. The ESBL gene
blaCTX-M-1 in combination with one of the phylogenetic groups,
blaCTX-M-15 in combination with phylogroup A or blaCTX-M-15 in
combination with resistance to gentamicin, chloramphenicol and
sulfamethoxazole/trimethoprim were quite common among popu-
lations. Our current approach provides interesting insight into
common clusters and speciﬁc clusters in ESBL-producing E. coli
from distinct sources. These results will be used for selection of
isolates with similar properties from different settings for further
molecular characterization to conﬁrm or exclude a transmission of
resistant strains or resistance gene carrying plasmids between dif-
ferent reservoirs.
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